Kimia Biosciences Ltd.
Snapshot View

39.90 +1.90 ▲5.0%

09 February 2023, 02:04:00 PM
Volume: 1,421

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kimiabiosciences.com
Market Cap 186.41 Cr.
Enterprise Value(EV) 228.88 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.52 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 30.86 Trailing Twelve Months Ending 2022-09
Book Value / Share 3.20 Trailing Twelve Months Ending 2022-09
Price to Book Value 12.29 Calculated using Price: 39.40
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 4.73 Cr. 47,312,741 Shares
FaceValue 1
Company Profile
The company is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+5.00%
1 Week
+3.91%
1 Month
-6.56%
3 Month
-11.33%
6 Month
-3.86%
1 Year
-12.31%
2 Year
-12.69%
5 Year
-22.60%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -34.59 -166.09 243.83 16.47 32.19 -22.22
Return on Capital Employed (%) -23.86 -135.77 -216.82 -18.30 11.83 16.94 8.94 16.13 -2.32
Return on Assets (%) -13.60 -33.62 -92.83 -11.72 4.76 6.24 1.83 5.31 -3.44

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 2 0 -4 -5 2 6 13 18 15 15
Non Curr. Liab. 1 1 7 9 25 29 34 37 32 34
Curr. Liab. 2 3 1 7 31 30 39 51 62 76
Minority Int.
Equity & Liab. 6 5 4 12 58 65 86 107 109 125
Non Curr. Assets 4 4 4 10 15 18 25 35 36 35
Curr. Assets 1 1 1 2 43 48 61 70 73 90
Misc. Exp. not W/O
Total Assets 6 5 4 12 58 65 86 107 109 125

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 6 2 0 1 76 94 106 133 125 140
Other Income 0 1 0 1 1 1 1 2 1 1
Total Income 7 2 0 2 77 95 107 135 126 141
Total Expenditure -7 -4 -4 -2 -74 -88 -102 -124 -124 -138
PBIDT 0 -1 -3 0 3 7 5 11 2 4
Interest 0 0 -1 0 -1 -2 -3 -3 -4 -4
Depreciation 0 0 0 0 -1 -1 -2 -2 -3 -3
Taxation 0 0 0 0 0 0 0 0 1 1
Exceptional Items
PAT -1 -2 -4 -1 2 4 1 5 -4 -2
Adjusted EPS -1 -2 -5 -1 1 3 0 1 -1 -1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 1 0 -6 -1 -7 -3 0 6 8
Cash Fr. Inv. -1 0 0 0 -6 -2 -2 -9 -14 -1
Cash Fr. Finan. -1 0 0 6 7 10 4 8 8 -8
Net Change 0 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 1 0 0 1 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94 74.94
Public 25.06 25.06 25.06 25.06 25.06 25.06 25.06 25.06 25.06
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 06 Feb 2023
Board Meeting Intimation for Intimation Of Board Meeting Of The Company And Continuation Of Closure Of Trading Window
Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve This is to inform you that a meeting of the Board of Directors is scheduled to be held on Tuesday February 14 2023 at3:00 pm (IST) at the corporate office of the Company 974 9th Floor Aggarwal Millennium Tower-II NetajiSubhash Place Pitampura New Delhi-110034 to transact the following businesses amongst others:i. To consider and approve the un-audited financial results on a standalone basis of the Company forquarter and nine months ended December 31 2022 in accordance with Regulation 33 of SEBI (ListingObligation and Disclosure Requirements) Regulations 2015;ii. Any other matter as may be considered and transacted with permission of Board of Directors.
Wed, 01 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. The Company has received the intimation letter from our Registrar & Transfer Agent Beetal Financial Services Private Limited regarding the request received for issuance of duplicate share certificates the details of which are envisaged hereunder:S. No Name Folio No Certificate No. Distinctive Number Shares1. Saroj Devi Chindalia 1198 828 1316701-1317400 700 Pursuant to SEBI Circular No. SEBI/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25 2022 a letter of confirmation will be issued to the securities holder/ claimant upon completion of necessary procedures regarding duplicate share certificates.
Mon, 30 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir/ Madam In reference to the earlier intimation dated 24.01.2023 Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015. The Company has received the intimation letter from our Registrar & Transfer Agent Beetal Financial Computer Services Private Limited regarding the issuance of duplicate share certificates.The details of shareholders is envisaged as under:-NAME OF THE SHAREHOLDER FOLIO NO NEW CERTIFICATE NO DISTINCTIVE NOFROM-TO NO. OF SHARESRAM BABU GUPTA 11953 10842 2401801-2401900 100

Technical Scans View Details >>

Wed, 08 Feb 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,005.80 -0.7%
Cipla Ltd. 83,886.47 1,022.70 -1.6%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,501.70 +0.3%
Divi's Laboratories Ltd. 74,340.49 2,814.25 +0.5%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,388.35 -0.1%
Torrent Pharmaceuticals Ltd. 52,675.65 1,541.15 -1.0%
Zydus Lifesciences Ltd. 47,993.66 474.10 +0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,005.80 -0.7%
Cipla Ltd. Consolidated 2022-12 31.80 1,022.70 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,501.70 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,814.25 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,388.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,541.15 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 474.10 +0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,005.80 -0.7%
Cipla Ltd. Consolidated 2022-12 3.70 1,022.70 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,501.70 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,814.25 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,388.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,541.15 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 474.10 +0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,005.80 -0.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,022.70 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,501.70 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,814.25 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,388.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,541.15 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 474.10 +0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.80 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,022.70 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,501.70 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,814.25 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,388.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.10 +0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.80 -0.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,022.70 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,501.70 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,814.25 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,388.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,541.15 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.10 +0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,005.80 -0.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,022.70 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,501.70 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,814.25 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,388.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,541.15 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 474.10 +0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,005.80 -0.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,022.70 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,501.70 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,814.25 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,388.35 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,541.15 -1.0%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 474.10 +0.0%

FAQ's On Kimia Biosciences Ltd.

What is Kimia Biosciences share price?

Can I buy Kimia Biosciences shares now?

What is the Market Cap of Kimia Biosciences?

What are the key metrics to analyse Kimia Biosciences?

What is the 52 Week High and Low of Kimia Biosciences?

What is the trend of Kimia Biosciences share price?